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Abstract
Background:  Cancer incidence varies by socioeconomic group and these variations have been linked with
environmental and lifestyle factors, differences in access to health care and health seeking behaviour. Socioeconomic
variations in cancer incidence by region and age are less clearly understood but they are crucial for targeting prevention
measures and health care commissioning.
Methods: Data were obtained from all eight English cancer registries for patients diagnosed between 1998 and 2003,
for all invasive cases of female breast cancer (ICD-10 code C50), lung cancer (ICD-10 codes C33-C34), cervical cancer
(ICD-10 code C53), and malignant melanoma of the skin (ICD-10 code C43). Socioeconomic status was assigned to each
patient based on their postcode of residence at diagnosis, using the income domain of the Index of Multiple Deprivation
2004. We analysed the socioeconomic variations in the incidence of breast, lung and cervical cancer and malignant
melanoma of the skin for England, and regionally and by age.
Results: Incidence was highest for the most deprived patients for lung cancer and cervical cancer, whilst the opposite
was observed for malignant melanoma and breast cancer. The difference in incidence between the most and the least
deprived groups was higher for lung cancer patients aged under 65 at diagnosis than those over 65 at diagnosis, which
may indicate a cohort effect. There were regional differences in the socioeconomic gradients with the gap being widest
for lung and cervical cancer in the North (North East, North West and Yorkshire and Humberside) and for malignant
melanoma in the East and South West. There were only modest variations in breast cancer incidence by region. If the
incidence of lung and cervical cancer were decreased to that of the least deprived group it would prevent 36% of lung
cancer cases in men, 38% of lung cancer cases in women and 28% of cervical cancer cases. Incidence of breast cancer
and melanoma was highest in the least deprived group, therefore if all socioeconomic groups had incidence rates similar
to the least deprived group it is estimated that the number of cases would increase by 7% for breast cancer, 27% for
melanoma in men and 29% for melanoma in women.
Conclusion: National comparison of socioeconomic variations in cancer incidence by region and age can provide an
unbiased basis for public health prevention and health commissioning. Decreasing inequalities in incidence requires the
integration of information on risk factors, incidence and projected incidence but targeted public health interventions
could help to reduce regional inequalities in incidence and reduce the future cancer burden.
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Background
Incidence for many cancers varies by socioeconomic
group in the UK [1-3] and other countries [4-6]. Socioeco-
nomic variations have been attributed to environment
[7], lifestyle [8,9], biological effects [10], access to health
care [11-17] and health seeking behaviour [18-21]. These
variations are particularly wide for the cancers under study
(breast, cervix, lung, malignant melanoma) due to the
close association between socioeconomic status and risk
factors. Inequalities in mortality[22] and survival [5,23-
30] have been evaluated to assess improvements in ineq-
uities in outcome and access to treatment. National com-
parison of socioeconomic variations in cancer incidence
by region and age are less understood but provide an
unbiased basis for prevention and commissioning. Previ-
ous studies have focused on regional variations [22,31]
with one recent study of regional and socioeconomic var-
iation in breast and lung cancer[32], although this did not
include age variations. This study aims to investigate
socio-economic differences in breast, lung, cervical and
malignant melanoma cancer incidence among patients
diagnosed in England during 1998–2003, by region and
age.
Methods
Data were obtained from all eight English cancer registries
for patients diagnosed between 1998 and 2003, for all
invasive cases of female breast cancer (ICD-10 code C50),
lung cancer (ICD-10 codes C33-C34), cervical cancer
(ICD-10 code C53), and malignant melanoma of the skin
(ICD-10 code C43). These cancer sites were selected due
to their association with risk factors closely linked to soci-
oeconomic status, such as smoking, UV exposure, HPV
infection and reproductive factors. Breast and cervical can-
cer were of specific interest due to socioeconomic varia-
tions in screening up-take.
A socioeconomic group was assigned to each patient
based on their postcode of residence at diagnosis, using
the income domain of the Index of Multiple Deprivation
2004 (IMD) [33]. IMD is a national measure of depriva-
tion for each Lower Super Output Area in England based
on information collected at census and in government
databases, such as income support and job seekers allow-
ance. IMD is based on seven domains of deprivation
(income, employment, health deprivation and disability,
education skills and training, barriers to housing and serv-
ices, crime and living environment). To exclude the health
related measures of the IMD, only the income domain of
the IMD was used in this study. This has been shown to
strongly correlated with deprivation and exclude health
related measures [25,34]. The national income domain of
the IMD for all lower super output areas (LSOAs) in Eng-
land was ranked in ascending order and divided into
quintiles, each containing 20% of the total population of
England [35], with quintile 1 being least deprived fifth of
the population and quintile 5 the most deprived fifth of
population. Super output areas are geographies that were
introduced by the Office for National Statistics (ONS) in
and attempt to create a uniform geographic system across
England for analysis that stays stable over time. There are
32,482 lower super output areas (LSOAs) in England with
an average population size of 1,500 residents [36].
European age-standardised incidence rates (ASRs) were
calculated by deprivation quintile, cancer site, Govern-
ment Office Region (GOR) (Figure 1), age group (under
65, 65 and over) and gender. Rate Ratios (RR) were calcu-
lated by region and age (under 65 and 65 and over) using
the least deprived (quintile 1) as the baseline. The number
(and percentage) of additional/fewer incident cases that
would be expected if incidence rates in all deprivation
groups was the same as those in the least deprived was
estimated. The difference between the observed and
expected number of cases for socioeconomic group was
calculated to provide an estimate of the burden of cancer
should these inequalities change. All analyses were done
in EXCEL and STATA 8.0 [37].
This study was carried out in association with the United
Kingdom association of Cancer Registries (UKACR) which
collect and conduct cancer surveillance using the data they
collect under Section 60 of the Health and Social Care Act
2002. The study used an anonymised dataset and separate
ethical approval was not required.
Results
The highest incidence rates in England occurred in the
most deprived groups for both lung cancer and cervical
cancer, while the opposite was the case for malignant
melanoma and breast cancer with the least deprived
groups having the highest incidence (Table 1). The ine-
quality between the least deprived, and the most
deprived was highest for lung cancer in men (RR 2.53
95% CI: 2.48–2.58) and women (RR 2.73 95% CI: 2.66–
2.80). Similarly, cervical cancer incidence was highest in
the most deprived group (RR 2.08 95% CI: 1.97–2.19)
and decreased consistently with increasing affluence. If
all population groups has the same incidence rates as the
least deprived group, we would expect 41,076 (36%)
fewer lung cancer cases in men, 28,148 (38%) fewer
cases in women and 4,108 (28%) fewer cervical cancer
cases. Breast cancer incidence was highest in the least
deprived with modest differences between socioeco-
nomic groups (Breast: RR 0.84 95% CI: 0.82–0.85).
Malignant melanoma incidence showed wide variations
by socioeconomic status but similar trends for men and
women (Melanoma in men: RR 0.49 95% CI: 0.47–0.52,
Melanoma in women: RR 0.48 95% CI: 0.46–0.51). If
the socioeconomic-specific incidence rates where equalBMC Cancer 2008, 8:271 http://www.biomedcentral.com/1471-2407/8/271
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Map of Regions in UK Figure 1
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to those in the least deprived quintile across all popula-
tion groups the number of breast cancer cases would rise
by 15,496 (7%) and cases of malignant melanoma of the
skin would increase by 4,286 (27%) in men and 5,862
(29%) in women.
There were only modest differences in socioeconomic-
specific breast cancer incidence rates both between and
within regions, with the highest in the East Midlands (RR
0.89 95% CI 0.85–0.94) and the lowest in London (RR
0.79 95% CI 0.76–0.83) (Figure 2). Socioeconomic varia-
tions by age were small and not significantly different for
women aged under 65 and over 65 (Figure 3).
Cervical cancer incidence varied substantially within
regions by socioeconomic group with a large increase in
incidence occurring between the second and the most
deprived group in most regions, except London and the
East of England. This difference was most significant in
the South West with an age standardised incidence rate of
10.3 per 100,000 (95% CI: 9.1–11.5) in the second most
deprived and 15.5 per 100,000 (95% CI: 13.3–17.7) in
the most deprived group. Socioeconomic-specific inci-
dence rates in general, as well as the difference between
the most and least deprived were lowest in London and
the East of England. In contrast the highest incidence rates
were recorded in deprived groups in the North West and
South West. The gap between most and least deprived was
Table 1: Incidence by socioeconomic status for lung, breast, cervical, and melanoma cancer, England, 1998–2003
Men Women
Deprivation No. AVR RR Excess cases 
compared to least 
deprived
% Deprivation No. AVR RR Excess cases 
compared to least 
deprived
%
Lung Lung
Least Deprived 15177 42.2 1.00 - Least Deprived 9024 21.1 1.00 -
2 19341 51.1 1.21 -3296 2 12015 25.7 1.22 -2782
3 22572 52.1 1.46 -7143 3 14286 30.7 1.46 -4504
4 26125 79.2 1.87 -12,137 4 17246 40.5 1.92 -8281
Most Deprived 30573 107.4 2.53 -18499 Most Deprived 20789 57.5 2.73 -13180
Total 113788 -41076 -36.1 Total 73360 -28148 -38.4
Melanoma Melanoma
Least Deprived 4239 12.8 1.00 - Least Deprived 5217 14.8 1.00 -
2 3908 11.5 0.90 425 2 4901 13.3 0.90 539
3 3368 10.3 0.81 796 3 4356 11.8 0.80 1099
4 2571 8.5 0.67 1292 4 3506 9.9 0.67 1715
Most Deprived 1724 6.3 0.49 1772 Most Deprived 2352 7.2 0.484 2509
Total 15810 4286 Total 20332 5862 28.8
Breast
Least Deprived 46085 125.7 1.00 -
2 46745 121.6 0.97 1557
3 44718 118.1 0.94 2859
4 39800 112.6 0.90 4643
Most Deprived 32672 105.0 0.84 2509
Total 210020 7.4
Cervix
Least Deprived 2149 6.4 1.00 -
2 2515 7.2 1.13 -289
3 2782 7.8 1.23 -520
4 3362 9.9 1.54 -1185
Most Deprived 4072 13.3 2.08 -2113
Total 14880 -4108 -27.6BMC Cancer 2008, 8:271 http://www.biomedcentral.com/1471-2407/8/271
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greatest in the North West and Yorkshire and Humber-
side. The deprivation gap was not statistically different
between those under 65 and 65 and over.
Incidence rates for lung cancer were 40% lower in women
than men however the trends by age and regional were
still similar. The highest incidence rates occurred in the
most deprived group for both men and women in the
North East and North West, with the lowest occurring in
the East of England (Figure 2). The North East and West
Midlands had the highest deprivation gap in men, with
the North West and North East having the highest for
women. Lung cancer was the only site with a significant
difference in the deprivation gap by age group with those
aged under 65 having a higher gap (men: RR 3.29 95% CI:
3.16–3.41, women: RR 3.18 95% CI 3.03–3.34) than
those age 65 and over (men: RR 2.26 95% CI 2.20–2.30
and women: RR 2.29 95% CI 2.42–2.56) (Figure 4).
The deprivation gap for malignant melanoma was similar
in men and women, with the exception of the North East
where it was larger in men, and the South West, where it
is larger in women. Incidence was higher for each socioe-
conomic group and the deprivation gap narrower in the
South West than in other regions, for both men (RR 0.84
95% CI: 0.70–1.00) and women (RR 0.69 95% CI: 0.58–
0.81). In the North East there was some inconsistency in
socioeconomic-specific incidence for malignant
melanoma as incidence in the second least deprived
group had lower incidence than the socioeconomic
groups on either side. London had the lowest incidence
Breast cancer incidence (European age-standardised rate per 100,000) by Government Office Region, England, 1998–2003 Figure 2
Breast cancer incidence (European age-standardised rate per 100,000) by Government Office Region, England, 
1998–2003.
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for all deprivation groups, in men and women. The largest
difference between least and most deprived occurred in
West Midlands for men (RR 0.43 95% CI: 0.36–0.51) and
Yorkshire and Humber for women (RR 0.38 95% CI:
0.32–0.44).
Discussion
Socioeconomic variations in cancer are of interest to
inform public health prevention and health care plan-
ning, particularly in developing programmes to reduce
inequalities in health, for which there are key targets in
England [38,38]. While survival and mortality can be
influence in the short term cancer incidence requires the
latent period before any impacts can be evaluated. Despite
this lag time evaluations of cancer, particularly by age,
region and deprivation, can assist in public health plan-
ning and targeted prevention.
Women in the least deprived socioeconomic groups have
higher breast cancer incidence which has been attributed
to the association of socioeconomic status with reproduc-
tive factors [39] and has been seen in other studies [4,40].
Women from a less deprived socioeconomic group may
be more likely to have their first child at a later age, have
fewer children in their lifetime and take hormone replace-
ment therapy, with each of these factors associated with
increased breast cancer incidence [39-41]. Breast cancer is
associated with obesity in post-menopausal women, with
the association particularly strong for deprived women
[42]. Deprived women have lower levels of screening up-
take to the national mammographic screening pro-
gramme for 50 to 65 year olds (extended to 65 to 69 in
2007) [43-45], however there was little variation by soci-
oeconomic status. The constancy across regions and soci-
oeconomic status may possibly be due to high awareness
among all groups. The moderate variations in breast can-
cer incidence and deprivation gap across regions was con-
sistent with other studies by region and socioeconomic
status, with the socioeconomic differences in incidence
remaining constant for most regions over time [32]. A
Scottish study of inequalities in breast cancer survival
found the despite differential screening up-take inequali-
ties in survival had narrowed in the screening ages since
the implementation of the screening programme [46].
Cervical cancer screening began nationally in England in
1988 for women aged 20 to 65 years but the age at first
screening invitation was raised to 25 years in 2005 [47].
Screening detects dysplastic lesions and in situ (CIN III)
tumours that are then removed prior to developing into
invasive cervical cancer. Most cervical cancers develop as a
result of Human Papilloma Virus (HPV), an asympto-
Rate ratio for cancer incidence for patients in least to most deprived socioeconomic group, England, 1998–2003 Figure 4
Lung cancer incidence in men (European age-standardised rate per 100,000) by Government Office Region, 
England, 1998–2003.
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matic sexually transmitted infection which is carcino-
genic. HPV infection is associated with younger age and
higher number of partners [48-50], after adjusting for
these factors socioeconomic status was associated with
HPV infection in some studies [48,49] while others found
no significant association [50]. Screening up-take has
been reported to vary by socioeconomic status [51] and be
lower for women with low levels of education in England
[52]. The lower incidence rates of cervical cancer for
Southern England (East, South West, London and South
East) are consistent with other national studies [31]. Soci-
oeconomic-variations in screening up-take contribute to
the regional variations in deprivation gap, although the
regional variations and influence of HPV infection (and
associated risk factors) remains an area for further study.
The high lung cancer incidence and deprivation gap in
this study is consistent with other studies [31,32]. Smok-
ing is strongly associated with socioeconomic status with
over 80% of lung cancer cases are estimated to be attribut-
able to smoking [53,54]. Smoking prevalence rapid
decreased during the 1970s and 1980s, with larger
decreases occurring in the non-manual groups [55] which
is consistent with an increase in the deprivation differ-
ences found in other studies [32]. Smoking prevalence in
2006 was higher in the manual occupational groups
(27%) than the non-manual groups (17%)[56]. Manual
groups were also associated with higher tobacco con-
sumption and beginning smoking at an earlier age [56].
Smoking prevalence by socioeconomic status is not cur-
rently available. While occupational and socioeconomic
status can not be directly compared evidence suggests that
the manual occupational groups are more similar to the
more deprived, than the least deprived.
The large deprivation-specific differences found in inci-
dence rates for patients diagnosed with lung cancer under
65, may indicate a cohort effect. In contrast to older ages
where rapid decreases in smoking occurred during the
1970s and 1980s there have been larger decreases in the
proportion of young men smoking than young women
[55,56]. A large cross-sectional study of socioeconomic
gradients in smoking among young women in Southamp-
ton, England found the prevalence of smoking was high-
est among the most deprived [57] with the socioeconomic
differences increasing with age, as smoking cessation was
more common in the least deprived. These trends may
suggest a cohort effect with continuing inequalities in
lung cancer incidence by age, continued monitoring of
smoking prevalence is key to assessing these. In June 2007
a national smoking ban in enclosed public spaces was
introduced, it remains to be seen if this will decrease
smoking prevalence and/or tobacco consumption.
Incidence of malignant melanoma of the skin in England
is expected to increase by 88% in men (66% in women)
by 2020 [58], with regional variations in these increases
[59]. Regional variations in skin cancer have also been
seen in other countries with variations attributed to UV
exposure and opportunities for recreational exposure [60-
62]. Within the UK the South West receives the most UV
exposure [49] and also has an older population with both
contributing to the high incidence of malignant
melanoma. Exposure to UV has increasingly occurred
through sun bed use and holidays abroad which are both
significantly associated with malignant melanoma [60].
Higher incidence in the least deprived and regional varia-
tions may be largely explained by holidays abroad and
exposure to natural UV, however current UV exposure
highlights changes to these trends. It is difficult to esti-
mate sun bed use as most are private and unregulated
however, anecdotal evidence suggests that sun bed use is
increasing in England particularly for teenagers and young
adults and may represents a cohort of individuals at
higher risk in the future. Exposure to sunbeds before the
age of 35 was increased the risk of malignant melanoma
by 75% [63]. A study in Dundee, Scotland found the
number of sun parlours has increased by up to 30% since
1998 and that 83% of the sun beds exceeded the Euro-
pean standard for UV(B) radiation levels [64]. There is
increasing access to sun beds through private unmanned
sun parlours, with sun parlours tending to be clustered in
areas of deprivation [65]. The cohort of high risk individ-
uals may represent a substantial burden of future skin
cancer.
Cancer registries in England collect data to a national spec-
ification and have high levels of case ascertainment and
consistency [66]. However, there is probably some regional
variation due to differences in data collection and timeli-
ness, although this is unlikely to explain the magnitude of
differences. Completeness of registration information, such
as treatment and stage is known to be less complete for
deprived patients [67,68]. These variations would only
influence the results of this study if a patients' diagnosis
date were changed, and even in this case very little impact
would be expected due to grouping of years, however this
is unlikely due to the high quality of registry data [66].
Ascertainment of lung and breast cancers are known to be
high although [69] regional variations in ascertainment of
malignant melanoma have been shown for the early 1990s
[31,70,71] with late stage tumours more likely to be regis-
tered [72]. Increased use of hospital admission system data
in the late 1990s and 2000s would be expected to improved
ascertainment, although no direct comparison of this has
been published.
Ecological measures of socioeconomic status have been
widely used by population-based cancer registries [25,34]
and in the absence of individual measures of socioeco-
nomic status are a pragmatic choice. As socioeconomic
status is based on area of residence at diagnosis it may notBMC Cancer 2008, 8:271 http://www.biomedcentral.com/1471-2407/8/271
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necessarily be representative of every patient's current or
historical socioeconomic group and the associated cancer
risk factors. However, generally people living in the same
area have similar levels of deprivation and have found to
be robust over time [34]. This is particularly relevant for
cancers where exposure to risk factors occurs years or dec-
ades before cancer diagnosis. Alternative measures of soci-
oeconomic status based on individual level data, such as
education, occupation or income are also frequently used
although cancer registries do not routinely collect these.
Conclusion
In the long-term decreasing socioeconomic variations in
incidence will have a substantial impact on the burden of
cancer, for both incidence and mortality. Variations in
regional lung and cervical cancer and malignant
melanoma rates highlight variations in exposure to risk
factors. Lung cancer trends identified larger inequalities in
those under 65 at diagnosis, while there were substantial
regional and age specific variations for malignant
melanoma. Socioeconomic variations in survival can
potentially be targeted more quickly while efforts to
change incidence will take many years to show any bene-
ficial impact however, in the long term, decreasing ine-
qualities in incidence will also decrease mortality and
decrease the number of incident cases.
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